These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
297 related articles for article (PubMed ID: 16574629)
1. Advanced glycation end products and diabetic complications: a general overview. Peppa M; Vlassara H Hormones (Athens); 2005; 4(1):28-37. PubMed ID: 16574629 [TBL] [Abstract][Full Text] [Related]
2. Methylglyoxal and Advanced Glycation End Products in Patients with Diabetes - What We Know so Far and the Missing Links. Groener JB; Oikonomou D; Cheko R; Kender Z; Zemva J; Kihm L; Muckenthaler M; Peters V; Fleming T; Kopf S; Nawroth PP Exp Clin Endocrinol Diabetes; 2019 Sep; 127(8):497-504. PubMed ID: 28407670 [TBL] [Abstract][Full Text] [Related]
3. Glycoxidation and wound healing in diabetes: an interesting relationship. Peppa M; Raptis SA Curr Diabetes Rev; 2011 Nov; 7(6):416-25. PubMed ID: 21846325 [TBL] [Abstract][Full Text] [Related]
4. [Advanced glycation end products and hyperglycaemia]. Omsland TK; Bangstad HJ; Berg TJ; Kolset SO Tidsskr Nor Laegeforen; 2006 Jan; 126(2):155-8. PubMed ID: 16415936 [TBL] [Abstract][Full Text] [Related]
5. Advanced Glycation End Products: Potential Mechanism and Therapeutic Target in Cardiovascular Complications under Diabetes. Yang P; Feng J; Peng Q; Liu X; Fan Z Oxid Med Cell Longev; 2019; 2019():9570616. PubMed ID: 31885827 [TBL] [Abstract][Full Text] [Related]
6. TAGE (toxic AGEs) theory in diabetic complications. Sato T; Iwaki M; Shimogaito N; Wu X; Yamagishi S; Takeuchi M Curr Mol Med; 2006 May; 6(3):351-8. PubMed ID: 16712480 [TBL] [Abstract][Full Text] [Related]
7. Skin fluorescence as a clinical tool for non-invasive assessment of advanced glycation and long-term complications of diabetes. Fokkens BT; Smit AJ Glycoconj J; 2016 Aug; 33(4):527-35. PubMed ID: 27287226 [TBL] [Abstract][Full Text] [Related]
8. Towards newer molecular targets for chronic diabetic complications. Khan ZA; Farhangkhoee H; Chakrabarti S Curr Vasc Pharmacol; 2006 Jan; 4(1):45-57. PubMed ID: 16472176 [TBL] [Abstract][Full Text] [Related]
9. New potentials for 3-hydroxy-3-methyl-glutaryl-coenzymeA reductase inhibitors: Possible applications in retarding diabetic complications. Bahrambeigi S; Rahimi M; Yousefi B; Shafiei-Irannejad V J Cell Physiol; 2019 Nov; 234(11):19393-19405. PubMed ID: 31004363 [TBL] [Abstract][Full Text] [Related]
10. Dicarbonyls and Advanced Glycation End-Products in the Development of Diabetic Complications and Targets for Intervention. Brings S; Fleming T; Freichel M; Muckenthaler MU; Herzig S; Nawroth PP Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28475116 [TBL] [Abstract][Full Text] [Related]
11. AGEs, rather than hyperglycemia, are responsible for microvascular complications in diabetes: a "glycoxidation-centric" point of view. Chilelli NC; Burlina S; Lapolla A Nutr Metab Cardiovasc Dis; 2013 Oct; 23(10):913-9. PubMed ID: 23786818 [TBL] [Abstract][Full Text] [Related]
12. The "Metabolic Memory" Theory and the Early Treatment of Hyperglycemia in Prevention of Diabetic Complications. Testa R; Bonfigli AR; Prattichizzo F; La Sala L; De Nigris V; Ceriello A Nutrients; 2017 Apr; 9(5):. PubMed ID: 28452927 [TBL] [Abstract][Full Text] [Related]
13. Hyperglycemia, glycoxidation and receptor for advanced glycation endproducts: potential mechanisms underlying diabetic complications, including diabetes-associated periodontitis. Lalla E; Lamster IB; Drury S; Fu C; Schmidt AM Periodontol 2000; 2000 Jun; 23():50-62. PubMed ID: 11276765 [No Abstract] [Full Text] [Related]
14. Involvement of advanced glycation end-products in 'hyperglycemic memory'. Nishikawa T; Araki E J Diabetes Investig; 2016 May; 7(3):297-9. PubMed ID: 27330713 [TBL] [Abstract][Full Text] [Related]
15. Metabolic memory: mechanisms and implications for diabetic retinopathy. Zhang L; Chen B; Tang L Diabetes Res Clin Pract; 2012 Jun; 96(3):286-93. PubMed ID: 22209677 [TBL] [Abstract][Full Text] [Related]
16. [The role of carbonyl stress in the development of diabetic complications]. Makk-Merczel K; Szarka A Orv Hetil; 2019 Oct; 160(40):1567-1573. PubMed ID: 31565977 [TBL] [Abstract][Full Text] [Related]
17. The cellular and molecular mechanisms of diabetic complications. King GL; Brownlee M Endocrinol Metab Clin North Am; 1996 Jun; 25(2):255-70. PubMed ID: 8799700 [TBL] [Abstract][Full Text] [Related]
19. The Mechanisms of Inhibition of Advanced Glycation End Products Formation through Polyphenols in Hyperglycemic Condition. Khangholi S; Majid FA; Berwary NJ; Ahmad F; Aziz RB Planta Med; 2016 Jan; 82(1-2):32-45. PubMed ID: 26550791 [TBL] [Abstract][Full Text] [Related]
20. Potential benefit of inhibitors of advanced glycation end products in the progression of type II diabetes: a study with aminoguanidine in C57/BLKsJ diabetic mice. Piercy V; Toseland CD; Turner NC Metabolism; 1998 Dec; 47(12):1477-80. PubMed ID: 9867077 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]